HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human Complement C4B Allotypes and Deficiencies in Selected Cases With Autoimmune Diseases.

Abstract
Human complement C4 is one of the most diverse but heritable effectors for humoral immunity. To help understand the roles of C4 in the defense and pathogenesis of autoimmune and inflammatory diseases, we determined the bases of polymorphisms including the frequent genetic deficiency of C4A and/or C4B isotypes. We demonstrated the diversities of C4A and C4B proteins and their gene copy number variations (CNVs) in healthy subjects and patients with autoimmune disease, such as type 1 diabetes, systemic lupus erythematosus (SLE) and encephalitis. We identified subjects with (a) the fastest migrating C4B allotype, B7, or (b) a deficiency of C4B protein caused by genetic mutation in addition to gene copy-number variation. Those variants and mutants were characterized, sequenced and specific techniques for detection developed. Novel findings were made in four case series. First, the amino acid sequence determinant for C4B7 was likely the R729Q variation at the anaphylatoxin-like region. Second, in healthy White subject MS630, a C-nucleotide deletion at codon-755 led to frameshift mutations in his single C4B gene, which was a private mutation. Third, in European family E94 with multiplex lupus-related mortality and low serum C4 levels, the culprit was a recurrent haplotype with HLA-A30, B18 and DR7 that segregated with two defective C4B genes and identical mutations at the donor splice site of intron-28. Fourth, in East-Asian subject E133P with anti-NMDA receptor encephalitis, the C4B gene had a mutation that changed tryptophan-660 to a stop-codon (W660x), which was present in a haplotype with HLA-DRB1*04:06 and B*15:27. The W660x mutation is recurrent among East-Asians with a frequency of 1.5% but not detectable among patients with SLE. A meticulous annotation of C4 sequences revealed clusters of variations proximal to sites for protein processing, activation and inactivation, and binding of interacting molecules.
AuthorsDanlei Zhou, Michael Rudnicki, Gilbert T Chua, Simon K Lawrance, Bi Zhou, Joanne L Drew, Fatima Barbar-Smiley, Taylor K Armstrong, Miranda E Hilt, Daniel J Birmingham, Werner Passler, Jeffrey J Auletta, Sasigarn A Bowden, Robert P Hoffman, Yee Ling Wu, Wael N Jarjour, Chi Chiu Mok, Stacy P Ardoin, Yu Lung Lau, Chack Yung Yu
JournalFrontiers in immunology (Front Immunol) Vol. 12 Pg. 739430 ( 2021) ISSN: 1664-3224 [Electronic] Switzerland
PMID34764957 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2021 Zhou, Rudnicki, Chua, Lawrance, Zhou, Drew, Barbar-Smiley, Armstrong, Hilt, Birmingham, Passler, Auletta, Bowden, Hoffman, Wu, Jarjour, Mok, Ardoin, Lau and Yu.
Chemical References
  • Complement C4a
  • Complement C4b
Topics
  • Autoimmune Diseases (diagnosis, ethnology, genetics, immunology)
  • Case-Control Studies
  • Complement C4a (deficiency, genetics, immunology)
  • Complement C4b (deficiency, genetics, immunology)
  • DNA Copy Number Variations
  • Female
  • Gene Dosage
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Immunity, Humoral (genetics)
  • Male
  • Mutation
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: